Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide

2018175 citationsJournal Articlebronze Open Access

Authors

Annalisa Ruggeri · Hôpital Saint-Antoine

Myriam Labopin · Sorbonne Université

Andrea Bacigalupo · Ospedale Policlinico San Martino

Zafer Gülbaş · Kocaeli Üniversitesi

Yener Koç · Antalya IVF

Didier Blaise · Institut Paoli-Calmettes

Benedetto Bruno ·

Abstract

In patients with acute leukemia in first or second remission receiving haploidentical transplantation with PT-Cy, the use of PBSC increases the risk of acute GVHD, whereas survival outcomes are comparable. Cancer 2018;124:1428-37. © 2018 American Cancer Society.

Topics & Keywords

Hematopoietic Stem Cell Transplantation Mesenchymal stem cell research Liver physiology and pathology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 124, Issue 7, pp. 1428-1437

DOI: 10.1002/cncr.31228

Field-Weighted Citation Impact: 14.37